MétaCan
Menu
← Back to cohort
Record W6942169778 · doi:10.14288/1.0437998

Identification of pharmacogenetic variants influencing the likelihood of developing cancer treatment-induced mucositis using pathway analyses

2025· article· en· W6942169778 on OpenAlexaboutno aff

Bibliographic record

VenuecIRcle (University of British Columbia) · 2025
Typearticle
Languageen
FieldAgricultural and Biological Sciences
TopicMycorrhizal Fungi and Plant Interactions
Canadian institutionsnot available
Fundersnot available
KeywordsIdentification (biology)MucositisPharmacogeneticsCancerMEDLINE

Abstract

fetched live from OpenAlex

Methotrexate (MTX), a cornerstone cancer treatment, has contributed to improved 5-year event-free survival rates but is associated with 20-40% occurrence of mucositis, which is characterized by the development of painful inflammatory lesions largely focused along the alimentary tract that often leads to premature termination of cancer treatment and impacts survival. Previous studies identified individual genetic variants implicated in mucositis development. Considering the complex biological pathways involved in mucositis development highlighted in recent studies, we hypothesize that multiple genetic variants within these shared biological pathways contribute to the onset of MTX-induced mucositis. To identify gene pathways that are likely to impact mucositis risk, we captured genes associated with: (i) methotrexate pharmacokinetics/pharmacodynamics from PharmGKB; (ii) published pathobiological pathways (e.g., WNT/β-catenin signaling) predicted to underlie mucositis development using MSigDB/Enrichr; and novel pathways based on genes previously associated with mucositis from literature using StringDB. To pinpoint pathways highly enriched for genetic variations associated with mucositis development in methotrexate-treated children, we examined the joint association of genetic variants using the raw genome-wide genotyping and patient clinical data for a set of pediatric mucositis cases (n=131) and controls (n=366) treated with intravenous methotrexate across 6 Canadian academic hospitals. A final set of 18 non-redundant pathways with a priori evidence for association with treatment-induced mucositis were selected for analysis. Our study used a phenotypic permutation test to identify significant enrichment in the IL-6 and WNT/β-catenin signaling pathways in patients developing mucositis due to high-dose MTX (> 1000 mg/m2). Using these genetic findings and clinical data, we developed a machine learning algorithm for mucositis risk stratification in patients receiving high-dose IV-MTX and identified key features impacting risk. Our future direction will focus on replicating the findings. If validated, the results can guide clinical care for high-risk patients and inform diagnosis and prescribing decisions. Moreover, the highlighted pathobiological pathways may serve as future therapeutic targets for mitigating mucositis during cancer treatment. Our goal is to minimize MTX-induced adverse reactions and improve patient quality of life during cancer treatment.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.038
Threshold uncertainty score0.075

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0020.003
Science and technology studies0.0010.000
Scholarly communication0.0010.000
Open science0.0010.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.029
GPT teacher head0.249
Teacher spread0.221 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venuecIRcle (University of British Columbia)→Same topicMycorrhizal Fungi and Plant Interactions→French-language works237,207→